Hefei Fengle Seed Co.Ltd(000713) : the net profit in 2021 is expected to increase by 247% – 297%
Hefei Fengle Seed Co.Ltd(000713) (000713) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 175-200 million yuan, with a year-on-year increase of 247.19% – 296.79%. Due to the influence of land collection and storage and other factors, the non recurring profit and loss in the reporting period increased by 105 million yuan to 120 million yuan year-on-year. The recurring profit and loss increased by 20-30 million yuan year-on-year, mainly due to the large increase in the sales revenue of the company’s seed business and the year-on-year increase in net profit; Due to the increased investment in environmental protection and other factors, the net profit of agrochemical business decreased year-on-year.
Frontier Biotechnologies Inc(688221) : the product under development fb2001 is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia
Frontier Biotechnologies Inc(688221) (688221) announced on the 17th that the company’s product fb2001 under development is a covid-19 pneumonia virus protease inhibitor for injection, and the target is covid-19 pneumonia virus 3CL main protease. The product under development is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia. New drug research and development is a long-term work, and the sales of new drugs after listing is affected by multiple factors. Up to now, Pfizer’s oral covid-19 drug (paxlovid) has been authorized by the U.S. Food and Drug Administration for emergency use to treat non hospitalized patients with mild to moderate covid-19 pneumonia with adverse prognosis risk.
Shanghai Aj Group Co.Ltd(600643) : it is proposed to transfer 10% shares of Huagui life of RMB 128 million
Shanghai Aj Group Co.Ltd(600643) (600643) announced on January 17 that it plans to transfer 100 million shares of Huagui Life Insurance Co., Ltd. with RMB 128 million, accounting for 10% of its total share capital. This transaction can further enrich the company’s financial business sector.
Bus Online Co.Ltd(002188) : the pre profit in 2021 is 126 million to 176 million yuan, and the loss is reversed year-on-year
Bus Online Co.Ltd(002188) (002188) disclosed the performance forecast on January 17. It is estimated that the net profit in 2021 will be 126 million yuan – 176 million yuan, turning losses into profits year-on-year. During the reporting period, the company’s related party Zhongtian Meihao Group Co., Ltd. donated its 100% equity of Zhongtian Meihao service to the company free of charge. The business scale of donated assets increased rapidly, which had a great impact on the profit data. The acquisition and relocation of the company’s land and buildings has a great impact on the profit data of the current period. The company reversed the estimated liabilities of 19 million yuan due to winning the lawsuit, settlement and other reasons.
Shanghai Longyun Cultural Creation & Technology Group Co.Ltd(603729) : the shareholder Zhuo Shuying and the persons acting in concert intend to increase their holdings of the company’s shares
Shanghai Longyun Cultural Creation & Technology Group Co.Ltd(603729) (603729) announced on January 17 that Zhuo Shuying, a shareholder holding more than 5% of the company’s shares, and the persons acting in concert intend to increase their holdings of no less than 1% of the company’s shares by means of centralized bidding transaction, and there is no price range for this increase.
Shenzhen Jinjia Group Co.Ltd(002191) : the subordinate companies signed a strategic cooperation agreement with you and our industry
Shenzhen Jinjia Group Co.Ltd(002191) (002191) it was announced on January 17 that Yunnan yunshuo Technology Co., Ltd., a subsidiary of the company, recently signed a memorandum of strategic cooperation agreement with Shenzhen youwo Industry Co., Ltd. Hu Xin and Wang Tao, the shareholders of yunshuo technology, plan to transfer 8% of the equity of yunshuo Technology to you and our industry. Yunshuo technology has reached strategic cooperation and equity transfer with you and our industry, which is another close cooperation between the company and you and our group after jointly promoting the R & D and production of e-cigarettes.
Chunghsin Technology Group Co.Ltd(603996) : pre loss of 400 million to 450 million yuan in 2021
Chunghsin Technology Group Co.Ltd(603996) (603996) disclosed the performance forecast on January 17. It is estimated that the loss in 2021 will be 400 million yuan – 450 million yuan, mainly due to the credit impairment loss of 191 million yuan and the interest expense of 184 million yuan. According to preliminary accounting, the audited net profit of the company in 2021 may be negative, the operating income may be less than 100 million yuan, and the net assets at the end of the period may be negative. Meanwhile, after preliminary communication with the audit institution, the company’s 2021 financial report may continue to be issued with non-standard audit opinions. According to relevant regulations, the listing of the company’s shares may be terminated by Shanghai Stock Exchange.
Hunan Baili Engineering Sci & Tech Co.Ltd(603959) : the controlling shareholder intends to transfer 5% of the company’s shares
Hunan Baili Engineering Sci & Tech Co.Ltd(603959) (603959) announced on January 17 that the controlling shareholder of the company, Tibet Xinhai New Venture Capital Co., Ltd., plans to transfer 24.51 million shares of the company’s tradable shares without restrictions (accounting for 5% of the company’s total share capital) to Shanghai axing Investment Management Co., Ltd. The share transfer price is 14.99 yuan / share, and the total price is 367 million yuan. In addition, the controlling shareholder planned to transfer 6% of the company’s shares to Su Huan last September, and the equity transfer is still in progress.
Fujian Cosunter Pharmaceutical Co.Ltd(300436) : Anti covid-19 small molecule oral drug is still in the preclinical research stage
Fujian Cosunter Pharmaceutical Co.Ltd(300436) (300436) released a stock price announcement on the evening of January 17th, saying that the anti New Coronavirus small molecule oral Innovation Medicine project of Fujian Guangsheng Zhong Lin Biotechnology Co., Ltd., a subsidiary of the company, is still in the pre clinical research stage, and it is necessary to identify the preclinical candidate compounds (PCC) by the study of compound characterization. Complete preclinical pharmaceutical research and pharmacokinetic, pharmacodynamic, pharmacological and toxicological research in line with clinical registration declaration, and carry out phase I, II and III clinical research after obtaining the clinical (implied) license of nmpa. After obtaining the corresponding safety and efficacy data, submit the drug registration application to nmpa, obtain the drug registration certificate and pass the GMP compliance inspection of API, Only then can the project products be produced and sold.
Shandong Jiangquan Industry Co.Ltd(600212) : disclose the plan for the sale of major assets and plan to withdraw from the thermal power business
Shandong Jiangquan Industry Co.Ltd(600212) (600212) on January 17, it disclosed the plan for the sale of major assets, and planned to transfer the thermoelectric business asset group owned by the company to Linyi Xuyuan Investment Co., Ltd. in cash; At present, the audit and evaluation related to the transaction have not been fully completed, and it is expected that there will be a major asset restructuring. After the completion of the transaction, the company will strategically withdraw from the thermal power business, concentrate resources on strategic and business transformation, and focus on the business layout focusing on new energy charging and energy storage business.
Guangzhou Tinci Materials Technology Co.Ltd(002709) : the net profit in 2021 is expected to increase by 294% – 332%
Guangzhou Tinci Materials Technology Co.Ltd(002709) (002709) disclosed the performance forecast on January 14. It is estimated that the net profit in 2021 will be RMB 2.1 billion-2.3 billion, with a year-on-year increase of 294.09% – 331.62%. During the reporting period, the sales volume and price of lithium-ion battery material electrolyte products of the company increased significantly year-on-year, the self-production rate of raw materials of the company’s products increased continuously, and the overall profitability improved significantly.
Wanhua Chemical Group Co.Ltd(600309) : the net profit in 2021 is expected to increase by 139% – 151%
Wanhua Chemical Group Co.Ltd(600309) (600309) announced on January 17 that the net profit in 2021 is expected to be 24 billion yuan to 25.2 billion yuan, with a year-on-year increase of 139% to 151%; Earnings per share ranged from 7.64 yuan to 8.03 yuan. During the reporting period, the price of chemical products increased. The company’s MDI technical transformation, ethylene and other new production capacity and new devices were put into operation, the volume and price of main products such as polyurethane, petrochemical and fine chemicals increased simultaneously, and the operating performance increased significantly year-on-year.
